These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 23567998
41. Effect of mushroom diet on pharmacokinetics of gabapentin in healthy Chinese subjects. Toh DS, Limenta LM, Yee JY, Wang LZ, Goh BC, Murray M, Lee EJ. Br J Clin Pharmacol; 2014 Jul; 78(1):129-34. PubMed ID: 24168107 [Abstract] [Full Text] [Related]
42. L-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia. Huttunen J, Peltokangas S, Gynther M, Natunen T, Hiltunen M, Auriola S, Ruponen M, Vellonen KS, Huttunen KM. Sci Rep; 2019 Sep 06; 9(1):12860. PubMed ID: 31492955 [Abstract] [Full Text] [Related]
43. Transport of gabapentin, a gamma-amino acid drug, by system l alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells. Su TZ, Lunney E, Campbell G, Oxender DL. J Neurochem; 1995 May 06; 64(5):2125-31. PubMed ID: 7722496 [Abstract] [Full Text] [Related]
44. Pharmacokinetic of gabapentin 600 mg tablet in Thai healthy subjects. Wittayalertpanya S, Chompootaweep S, Thaworn N, Khemsri W, Prompila N, Sayankuldilok N, Punyasang W. J Med Assoc Thai; 2012 Apr 06; 95(4):583-9. PubMed ID: 22612015 [Abstract] [Full Text] [Related]
45. The intestinal absorption mechanism of gabapentin makes it appropriate for gastroretentive delivery. Chen C, Cowles VE, Sweeney M. Curr Clin Pharmacol; 2013 Feb 01; 8(1):67-72. PubMed ID: 22946876 [Abstract] [Full Text] [Related]
46. Specific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging. Wei L, Tominaga H, Ohgaki R, Wiriyasermkul P, Hagiwara K, Okuda S, Kaira K, Oriuchi N, Nagamori S, Kanai Y. Cancer Sci; 2016 Mar 01; 107(3):347-52. PubMed ID: 26749017 [Abstract] [Full Text] [Related]
48. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2. Kantipudi S, Jeckelmann JM, Ucurum Z, Bosshart PD, Fotiadis D. Int J Mol Sci; 2020 Oct 14; 21(20):. PubMed ID: 33066406 [Abstract] [Full Text] [Related]
49. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Uchino H, Kanai Y, Kim DK, Wempe MF, Chairoungdua A, Morimoto E, Anders MW, Endou H. Mol Pharmacol; 2002 Apr 14; 61(4):729-37. PubMed ID: 11901210 [Abstract] [Full Text] [Related]
50. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM. Proc Natl Acad Sci U S A; 1999 Oct 12; 96(21):12079-84. PubMed ID: 10518579 [Abstract] [Full Text] [Related]
51. Population Pharmacokinetic Modelling of Morphine, Gabapentin and their Combination in the Rat. Papathanasiou T, Juul RV, Gabel-Jensen C, Kreilgaard M, Lund TM. Pharm Res; 2016 Nov 12; 33(11):2630-43. PubMed ID: 27380190 [Abstract] [Full Text] [Related]
52. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery. Puris E, Gynther M, Huttunen J, Auriola S, Huttunen KM. Eur J Pharm Sci; 2019 Mar 01; 129():99-109. PubMed ID: 30625368 [Abstract] [Full Text] [Related]
53. Noninvasive sampling of gabapentin by reverse iontophoresis. Nair AB, Kumria R, Al-Dhubiab BE, Attimarad M, Harsha S. Pharm Res; 2015 Apr 01; 32(4):1417-24. PubMed ID: 25319106 [Abstract] [Full Text] [Related]
54. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5). Cormerais Y, Massard PA, Vucetic M, Giuliano S, Tambutté E, Durivault J, Vial V, Endou H, Wempe MF, Parks SK, Pouyssegur J. J Biol Chem; 2018 Feb 23; 293(8):2877-2887. PubMed ID: 29326164 [Abstract] [Full Text] [Related]
55. Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Omidi Y, Campbell L, Barar J, Connell D, Akhtar S, Gumbleton M. Brain Res; 2003 Nov 14; 990(1-2):95-112. PubMed ID: 14568334 [Abstract] [Full Text] [Related]
56. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET. Wiriyasermkul P, Nagamori S, Tominaga H, Oriuchi N, Kaira K, Nakao H, Kitashoji T, Ohgaki R, Tanaka H, Endou H, Endo K, Sakurai H, Kanai Y. J Nucl Med; 2012 Aug 14; 53(8):1253-61. PubMed ID: 22743251 [Abstract] [Full Text] [Related]
57. Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptake. Kärkkäinen J, Gynther M, Kokkola T, Petsalo A, Auriola S, Lahtela-Kakkonen M, Laine K, Rautio J, Huttunen KM. Int J Pharm; 2018 Jun 10; 544(1):91-99. PubMed ID: 29669256 [Abstract] [Full Text] [Related]
58. Expression of LAT1 and LAT2 amino acid transporters in human and rat intestinal epithelial cells. Fraga S, Pinho MJ, Soares-da-Silva P. Amino Acids; 2005 Nov 10; 29(3):229-33. PubMed ID: 16027961 [Abstract] [Full Text] [Related]
59. Gabapentin concentrations and postmortem distribution. Hamm CE, Gary RD, McIntyre IM. Forensic Sci Int; 2016 May 10; 262():201-3. PubMed ID: 27038659 [Abstract] [Full Text] [Related]
60. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells. Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, Nagane M. Neurosurgery; 2008 Feb 10; 62(2):493-503; discussion 503-4. PubMed ID: 18382329 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]